Sanofi Settles 4,000 Lawsuits Over Zantac Cancer Claims
Sanofi SA has reached a settlement for about 4,000 lawsuits alleging that the company sold its Zantac heartburn medicine without disclosing its potential to cause cancer. This marks the first significant resolution of cases related to the product. The settlement will encompass litigation pending in courts outside of Delaware. It is reported that the deal could eventually cover as many as 5,000 cases.
Key Takeaways:
- Sanofi SA has agreed to settle approximately 4,000 lawsuits over the sale of Zantac.
- The settlement will apply to litigation pending in courts outside of Delaware.
- The deal could eventually cover as many as 5,000 cases.
Do You Know?
- Zantac is a heartburn medicine that has been the subject of numerous lawsuits due to claims of its potential to cause cancer.